Treatment initiation, program attrition and patient treatment outcomes associated with scale-up and decentralization of HIV care in rural Malawi
- PMID: 23077473
- PMCID: PMC3471893
- DOI: 10.1371/journal.pone.0038044
Treatment initiation, program attrition and patient treatment outcomes associated with scale-up and decentralization of HIV care in rural Malawi
Abstract
Objective: To describe patient antiretroviral therapy (cART) outcomes associated with intensive decentralization of services in a rural HIV program in Malawi.
Methods: Longitudinal analysis of data from HIV-infected patients starting cART between August 2001 and December 2008 and of a cross-sectional immunovirological assessment conducted 12 (±2) months after therapy start. One-year mortality, lost to follow-up, and attrition (deaths and lost to follow-up) rates were estimated with exact Poisson 95% confidence intervals (CI) by type of care delivery and year of initiation. Association of virological suppression (<50 copies/mL) and immunological success (CD4 gain ≥100 cells/µL), with type of care was investigated using multiple logistic regression.
Results: During the study period, 4322 cART patients received centralized care and 11,090 decentralized care. At therapy start, patients treated in decentralized health facilities had higher median CD4 count levels (167 vs. 130 cell/µL, P<0.0001) than other patients. Two years after cART start, program attrition was lower in decentralized than centralized facilities (9.9 per 100 person-years, 95% CI: 9.5-10.4 vs. 20.8 per 100 person-years, 95% CI: 19.7-22.0). One year after treatment start, differences in immunological success (adjusted OR=1.23, 95% CI: 0.83-1.83), and viral suppression (adjusted OR=0.80, 95% CI: 0.56-1.14) between patients followed at centralized and decentralized facilities were not statistically significant.
Conclusions: In rural Malawi, 1- and 2-year program attrition was lower in decentralized than in centralized health facilities and no statistically significant differences in one-year immunovirological outcomes were observed between the two health care levels. Longer follow-up is needed to confirm these results.
Conflict of interest statement
Figures
References
-
- UNAIDS, WHO (2009 November) AIDS epidemic update, 2008 Update. Geneva.
-
- Barth RE, van der Loeff MF, Schuurman R, Hoepelman AI, Wensing AM (2010) Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review. Lancet Infect Dis 10: 155–166. - PubMed
-
- UNAIDS, WHO, UNAIDS (2008 October) Epidemiological Fact Sheet on HIV and AIDS. Core data on epidemiology and response: Malawi, 2008 Update. Geneva, Switzerland. The World Health Organization website. Available: http://apps.who.int/globalatlas/predefinedReports/EFS2008/full/EFS2008_M.... Accessed 2012 May 7.
-
- UNGASS (2010 March) Malawi HIV and AIDS Monitoring and Evaluation Report: 2008–2009. UNGASS Country Progress Report. The UNAIDS website. Available: http://www.unaids.org/en/dataanalysis/monitoringcountryprogress/2010prog.... Accessed 2012 May 7.
-
- Lowrance DW, Makombe S, Harries AD, Shiraishi RW, Hochgesang M, et al. (2008) A public health approach to rapid scale-up of antiretroviral treatment in Malawi during 2004–2006. J Acquir Immune Defic Syndr 49: 287–293. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
